Uncommon neurodegenerative causes of dementia

International Psychogeriatrics

Volumn 17, Issue SUPPL. 1, 2005, Pages

  Kurz, Alexander F ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Amyotrophic lateral sclerosis with dementia; Corticobasal degeneration; Frontotemporal degenerations; Huntington's disease; Posterior cortical atrophy; Progressive supranuclear palsy

Indexed keywords

AMANTADINE; ANTIDEPRESSANT AGENT; ANTIPARKINSON AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; CHOLINESTERASE INHIBITOR; CLONAZEPAM; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; MEMANTINE; MIRTAZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; RILUZOLE; SEROTONIN UPTAKE INHIBITOR; TRAZODONE;

AGED; AGGRESSION; ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; APHASIA; BEHAVIOR DISORDER; BEHAVIOR THERAPY; BRADYKINESIA; BRAIN ATROPHY; BRAIN DEGENERATION; CHOREA; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; CORTICOBASAL DEGENERATION; DELUSION; DEMENTIA; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DYSTONIA; EXTRAPYRAMIDAL SYNDROME; FRONTAL LOBE; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; HALLUCINATION; HISTOPATHOLOGY; HUMAN; HUNTINGTON CHOREA; HYPOKINESIA; MOTOR NEURON DISEASE; MUSCLE RIGIDITY; MYOCLONUS; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSESSIVE COMPULSIVE DISORDER; OCCUPATIONAL THERAPY; PARIETAL LOBE; PATHOPHYSIOLOGY; PERSONALITY DISORDER; PHYSIOTHERAPY; POSITRON EMISSION TOMOGRAPHY; POSTERIOR CORTICAL ATROPHY; PROGRESSIVE SUPRANUCLEAR PALSY; PSYCHOSIS; REVIEW; RISK FACTOR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STEREOTYPY; TEMPORAL LOBE; VISUAL DISORDER; ATROPHY; BRAIN CORTEX; DEPTH PERCEPTION; NERVE DEGENERATION; PATHOLOGY; PERCEPTION DISORDER; PHYSIOLOGY; VISION;

AMYOTROPHIC LATERAL SCLEROSIS; ATROPHY; BASAL GANGLIA DISEASES; CEREBRAL CORTEX; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; FRONTAL LOBE; HUMANS; HUNTINGTON DISEASE; NERVE DEGENERATION; PERCEPTUAL DISORDERS; PERSONALITY DISORDERS; SPACE PERCEPTION; SUPRANUCLEAR PALSY, PROGRESSIVE; TEMPORAL LOBE; VISUAL PERCEPTION;

EID: 33644815843     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610205001936     Document Type: Review

References (37)

1. Black, S. E. (1996). Focal cortical atrophy syndromes. Brain and Cognition, 31, 188-229.
2. Boeve, B. F., Lang, A. E. and Litvan, I. (2003). Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Annals of Neurology, 54, S15-S19.
3. Bonelli, R. M., Wenning, G. K. and Kapfhammer, H. P. (2004). Huntington's disease: present treatments and future therapeutic modalities. International Clinical Psychopharmacology, 19, 51-62.
4. Chow, T. W., Miller, B. L., Hayashi, V. N. and Geschwind, D. H. (1999). Inheritance of frontotemporal dementia. Archives of Neurology, 56, 817-822.
5. Davies, S. and Ramsden, D. B. (2001). Huntington's disease. Molecular Patholology, 54, 409-413.
6. Diehl, J. and Kurz, A. (2002). Frontotemporal dementia: patient characteristics, cognition, and behavior. International Journal of Geriatric Psychiatry, 17, 914-918.
7. Diehl, J., Grimmer, T., Drzezga, A., Riemenschneider, M., Förstl, H. and Kurz, A. (2004). Cerebral metabolic patterns at early stages of frontotemporal dementia and semantic dementia. A PET study. Neurobiology of Aging, 25, 1051-1054.
8. Esmonde, T., Liles, E., Gibson, M. and Hodges, J. R. (1996). Neuropsychological performance, disease severity, and depression in progressive supranuclear palsy. Journal of Neurology, 243, 638-673.
9. Foster, N. L. et al. (1992). Progressive subcortical gliosis and progressive supranuclear palsy can have similar clinical and PET abnormalities. Journal of Neurology, Neurosurgery and Psychiatry, 55, 707-713.
10. Greicius, M. D., Geschwind, M. D. and Miller, B. L. (2002). Presenile dementia syndromes: an update on taxonomy and diagnosis. Journal of Neurology, Neurosurgery and Psychiatry, 72, 691-700.
11. Grimes, D. A., Lang, A. E. and Bergeron, C. B. (1999). Dementia as the most common presentation of cortico-basal ganglionic degeneration. Neurology, 53, 1969-1974.
12. Hampel, H. et al. (2004). Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer's disease. A comparative cerebrospinal fluid study. Archives of General Psychiatry, 61, 95-102.
13. Hodges, J. R., Garrard, P. and Patterson, K. (1998). Semantic dementia. In A. Kertesz and D. G. Munoz (Eds.) Pick's Disease and Pick Complex (pp. 83-104). New York: Wiley-Liss.
14. Hosaka, K. et al. (2002). Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration. Journal of the Neurological Sciences, 199, 67-71.
15. Hosler, B. A. et al. (2000). Linkage of familial amyotrophic lateral sclerosis with frontotemporal dementia to chromosome 9q21-q22. Journal of the American Medical Association, 284, 1664-1669.
16. Howard, R. S. and Orrell, R. W. (2002). Management of motor neurone disease. Postgraduate Medicine Journal, 78, 736-741.
17. Ikeda, M. et al. (2004). Efficacy of fluvoxamine as a treatment for behavioral symptoms in frontotemporal lobar degeneration patients. Dementia and Geriatric Cognitive Disorders, 17, 117-121.
18. Knopman, D. S., Petersen, R. C., Edland, S. D., Cha, R. H. and Rocca, W. A. (2004). The incidence of frontotemporal lobar degeneration in Rochester, Minnesota, 1990 through 1994. Neurology, 62, 506-508.
19. Litvan, I. et al. (1996). Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology, 47, 1-9.
20. Litvan, I. et al. (1997). Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology, 48, 119-125.
21. Majoor-Krakauer, D., Willems, P. J. and Hofman, A. (2003). Genetic epidemiology of amyotrophic lateral sclerosis. Clincal Genetics, 63, 83-101.
22. Mendez, M. F., Ghajarania, M. and Perryman, K. M. (2002). Posterior cortical atrophy: clinical characteristics and differences compared to Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 14, 33-40.
23. Mesulam, M. M. (2003). Primary progressive aphasia - a language-based dementia. New England Journal of Medicine, 349, 1535-1542.
24. Munoz, D. G. (1998). The pathology of Pick complex. In A. Kertesz and D. G. Munoz (Eds.) Pick's Disease and Pick Complex (pp. 211-241). New York: Wiley-Liss.
25. Nestor, P. J., Caine, D., Fryer, T. D., Clarke, J. and Hodges, J. R. (2003). The topography of metabolic deficits in posterior cortical atrophy (the visual variant of Alzheimer's disease). Journal of Neurology, Neurosurgery and Psychiatry, 74, 1521-1529.
26. Pavese, N. et al. (2003). Progressive striatal and cortical dopamine receptor dysfunction in Huntington's disease: a PET study. Brain, 126, 1127-1135.
27. Potter, N. T., Spector, E. B. and Prior, T. W. (2004). Technical standards and guidelines for Huntington disease testing. Genetic Medicine, 61-65.
28. Renner, J. A., Burns, H. J. M., Hou, C. E., McKeel, D. W., Storandt, M. and Morris, J. C. (2004). Progressive posterior cortical dysfunction: a clinicopathologic series. Neurology, 63, 1175-1180.
29. Riemenschneider, M. et al. (2002). Tau and Abeta42 protein in CSF of patients with frontotemporal degeneration. Neurology, 58, 1622-1628.
30. Rosen, H. J. et al. (2002). Patterns of brain atrophy in frontotemporal dementia and semantic dementia. Neurology, 58, 198-208.
31. Sergeant, N., Wattez, A. and Delacourte, A. (1999). Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively "exon 10" isoforms. Journal of Neurochemistry, 72, 1243-1249.
32. Sobrido, M. J. et al. (2003). Novel tau polymorphisms, tau haplotypes and splicing in familial and sporadic frontotemporal dementia. Archives of Neurology, 60, 698-702.
33. Sonty, S. P. et al. (2003). Primary progressive aphasia: PPA and the language network. Annals of Neurology, 53, 35-49.
34. Strong, M. J., Lomen-Hoerth, C., Caselli, R. J., Bigio, E. H. and Yang, W. (2003). Cognitive impairment, frontotemporal dementia, and the motor neuron diseases. Annals of Neurology, 54, S20-S23.
35. Tang-Wai, D. F. et al. (2004). Clinical, genetic, and neuropathologic characteristics of posterior cortical atrophy. Neurology, 63, 1168-1174.
36. Vonsattel, J. P. and DiFiglia, M. (1998). Hungtington disease. Journal of Neuropathology and Experimental Neurology, 57, 369-384.
37. Yoshida, T., Shiga, K., Yoshikawa, K., Yamada, K. and Nakagawa, M. (2004). White matter loss in the splenium of the corpus callosum in a case of posterior cortical atrophy: a diffusion tensor imaging study. European Neurology, 52, 77-81.